News
AORT
23.55
+4.81%
1.08
Artivion: PMA Approval Supports Accelerating Growth And Margin Expansion
Seeking Alpha · 1d ago
Artivion Earns Buy Rating as AMDS Wins Broader FDA Approval; Analyst Reiterates $36 Price Target
TipRanks · 1d ago
Artivion Seeks To Tap $150 Million US Market Opportunity With FDA Approval
Benzinga · 2d ago
Why Artivion (AORT) Is Up 17.3% After Full FDA PMA Approval for AMDS Hybrid Prosthesis
Simply Wall St · 2d ago
Artivion Gains FDA PMA Approval For AMDS Hybrid Prosthesis In Treating Aortic Dissections
NASDAQ · 2d ago
Artivion: FDA Approval Expands AMDS Market Opportunity; Buy Rating Reiterated with Unchanged $44 Price Target
TipRanks · 2d ago
Analysts Are Bullish on These Healthcare Stocks: LifeMD (LFMD), Artivion (AORT)
TipRanks · 2d ago
Artivion Wins FDA Approval For AMDS Hybrid Prosthesis
NASDAQ · 2d ago
Artivion Says FDA Approves Premarket Approval Application For AMDS Hybrid Prosthesis
Benzinga · 2d ago
Artivion Announces U.S. FDA Approval of the AMDS Hybrid Prosthesis
PR Newswire · 2d ago
Weekly Report: what happened at AORT last week (0622-0626)?
Weekly Report · 2d ago
3 Profitable Stocks We Keep Off Our Radar
Barchart · 6d ago
10 small-cap U.S. healthcare stocks with the weakest momentum grades
Seeking Alpha · 06/24 14:20
Analysts Offer Insights on Healthcare Companies: Artivion (AORT) and Pfizer (PFE)
TipRanks · 06/23 09:40
Weekly Report: what happened at AORT last week (0615-0619)?
Weekly Report · 06/22 10:08
Oversold Conditions For Artivion (AORT)
NASDAQ · 06/18 20:40
Artivion Price Target Maintained With a $36.00/Share by Canaccord Genuity
Dow Jones · 06/16 15:55
Artivion Is Maintained at Buy by Canaccord Genuity
Dow Jones · 06/16 15:55
Canaccord Genuity Reaffirms Their Buy Rating on Artivion (AORT)
TipRanks · 06/16 10:56
Weekly Report: what happened at AORT last week (0608-0612)?
Weekly Report · 06/15 10:09
More
Webull provides a variety of real-time AORT stock news. You can receive the latest news about Artivion, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About AORT
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons in treating patients with aortic diseases. The Company operates through two segments, which include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other products. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products. It is engaged in the endovascular repair of aortic arch disease and the developer of the NEXUS Aortic Arch System.